Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Patients With Advanced Breast Cancer Harboring TP53 Mutations With Dose-dense Cyclophosphamide - the p53 Breast Cancer Trial

NCT02965950 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT02965950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02965950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Patients With Advanced Breast Cancer Harboring TP53 Mutations With Dose-dense Cyclophosphamide - the p53 Breast Cancer Trial
Lead sponsor
Haukeland University Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 31, 2016
Completion date
May 31, 2033
Enrollment
190 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced breast cancer, metastatic breast carcinoma